May 20th


An estimation of pitavastatin efficiency and safety in the treatment of patients with high cardiovascular risk

Печать PDF

Kryuchkova O. N., Itskova E. A., Liebied I. I., Lutai J. A., Turna E. Y.

Crimea State Medical University, Simferopol, AR Crimea

Summary. The article shows the status of lowers lipids therapy's problem in patients with high cardiovascular risk. This article studies the representative of the latest generation statins − pitavastatin for secondary prevention in this category of patients. The use of pitavastatin was characterized by a high profile security have not negative impact to the level of liver enzymes and glucose metabolism. There was a tendency of reduction of glycosylated hemoglobin. Reliable hypolipid effect of pitavastatin was accompanied by increased levels of HDL cholesterol.

Keywords: cardiocovascular diseases, treatment, statines.